» Articles » PMID: 32218880

Engineering Protein Nanocages As Carriers for Biomedical Applications

Overview
Journal NPG Asia Mater
Date 2020 Mar 29
PMID 32218880
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Protein nanocages have been explored as potential carriers in biomedicine. Formed by the self-assembly of protein subunits, the caged structure has three surfaces that can be engineered: the interior, the exterior and the intersubunit. Therapeutic and diagnostic molecules have been loaded in the interior of nanocages, while their external surfaces have been engineered to enhance their biocompatibility and targeting abilities. Modifications of the intersubunit interactions have been shown to modulate the self-assembly profile with implications for tuning the molecular release. We review natural and synthetic protein nanocages that have been modified using chemical and genetic engineering techniques to impart non-natural functions that are responsive to the complex cellular microenvironment of malignant cells while delivering molecular cargos with improved efficiencies and minimal toxicity.

Citing Articles

A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework.

Gressler S, Hipfinger C, Part F, Pavlicek A, Zafiu C, Giese B J Nanobiotechnology. 2025; 23(1):90.

PMID: 39920688 PMC: 11804063. DOI: 10.1186/s12951-025-03113-7.


MoleQCage: Geometric High-Throughput Screening for Molecular Caging Prediction.

Kravberg A, Devaurs D, Varava A, Kavraki L, Kragic D J Chem Inf Model. 2024; 64(24):9034-9039.

PMID: 39665285 PMC: 11684736. DOI: 10.1021/acs.jcim.4c01419.


DNA-Regulated Multi-Protein Complement Control.

Ma Y, Winegar P, Figg C, Ramani N, Anderson A, Ngo K J Am Chem Soc. 2024; 146(48):32912-32918.

PMID: 39569872 PMC: 11755408. DOI: 10.1021/jacs.4c11315.


Recent Updates on Diverse Nanoparticles and Nanostructures in Therapeutic and Diagnostic Applications with Special Focus on Smart Protein Nanoparticles: A Review.

Muraleedharan A, Acharya S, Kumar R ACS Omega. 2024; 9(42):42613-42629.

PMID: 39464472 PMC: 11500139. DOI: 10.1021/acsomega.4c05037.


Protein Cage Directed Assembly of Binary Nanoparticle Superlattices.

Zhou Y, Shaukat A, Seitsonen J, Rigoni C, Timonen J, Kostiainen M Adv Sci (Weinh). 2024; 11(45):e2408416.

PMID: 39401426 PMC: 11615748. DOI: 10.1002/advs.202408416.


References
1.
Kaczmarczyk S, Sitaraman K, Young H, Hughes S, Chatterjee D . Protein delivery using engineered virus-like particles. Proc Natl Acad Sci U S A. 2011; 108(41):16998-7003. PMC: 3193192. DOI: 10.1073/pnas.1101874108. View

2.
Zhao Q, Chen W, Chen Y, Zhang L, Zhang J, Zhang Z . Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem. 2011; 22(3):346-52. DOI: 10.1021/bc1002532. View

3.
Kedersha N, Rome L . Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol. 1986; 103(3):699-709. PMC: 2114306. DOI: 10.1083/jcb.103.3.699. View

4.
Kickhoefer V, Han M, Raval-Fernandes S, Poderycki M, Moniz R, Vaccari D . Targeting vault nanoparticles to specific cell surface receptors. ACS Nano. 2009; 3(1):27-36. PMC: 2641028. DOI: 10.1021/nn800638x. View

5.
Naahidi S, Jafari M, Edalat F, Raymond K, Khademhosseini A, Chen P . Biocompatibility of engineered nanoparticles for drug delivery. J Control Release. 2012; 166(2):182-94. DOI: 10.1016/j.jconrel.2012.12.013. View